Journal: Experimental and Therapeutic Medicine
Article Title: LASP2 suppressed malignancy and Wnt/β-catenin signaling pathway activation in bladder cancer
doi: 10.3892/etm.2018.6836
Figure Lengend Snippet: LASP2 upregulation inhibits bladder cancer cell aggressiveness. (A) Western blotting analysis of LASP2 expression in EJ and T24 cells. (B) Representative images (left panel, ×200) and quantification (right panel) of EdU incorporation in EJ and T24 bladder cancer cells. DAPI was used as a DNA stain. Representative images (left panel) and quantification (right panel) of (C) HUVECs cultured on Matrigel-coated plates with conditioned medium from LASP2-overexpressing cells, (magnification, ×200) (D) migratory cells assessed using a wound healing assay and (E) migratory cells assessed using Transwell migration and Matrigel invasion assays, respectively (magnification, ×200). *P<0.05. EdU, 5-ethynyl-2′-deoxyuridine; HUVEC, human umbilical vein endothelial cell; LASP2, LIM and SH3 Protein 2.
Article Snippet: The bladder cancer cell line EJ (cat. no. CL-0274) was obtained from Procell Life Science and Technology Co., Ltd. (Wuhan, China), and 5637 (cat. no. TCHu 1), UM-UC-3 (cat. no. TCHu 217), T24 (cat. no. SCSP-536) and TCCSUP (cat. no. SCSP-571) bladder cancer cell lines were obtained from the Cell Bank of Chinese Academy of Sciences (Shanghai, China).
Techniques: Western Blot, Expressing, Staining, Cell Culture, Wound Healing Assay, Migration